期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
肺心标2号治疗慢性肺心病急性加重期热痰证的疗效观察 被引量:2
1
作者 郝琳 康娟 《中华中医药学刊》 CAS 北大核心 2015年第7期1790-1792,共3页
目的:观察肺心标2号治疗慢性肺源性心脏病急性加重期热痰证的临床疗效。方法:将72例符合纳入标准的患者随机分为治疗组和对照组(各36例)。对照组给予西医常规治疗,治疗组在西医常规治疗基础上加用肺心标2号,疗程为1周。观察两组治疗前... 目的:观察肺心标2号治疗慢性肺源性心脏病急性加重期热痰证的临床疗效。方法:将72例符合纳入标准的患者随机分为治疗组和对照组(各36例)。对照组给予西医常规治疗,治疗组在西医常规治疗基础上加用肺心标2号,疗程为1周。观察两组治疗前后临床症状、体征,检测C反应蛋白、PCT、血气分析指标。结果:1治疗组愈显率高于对照组,差异具有统计学意义(P<0.05),两组有效率比较差异无统计学意义(P>0.05)。2两组治疗后CRP、PCT较治疗前下降,差异具有统计学意义(P<0.05),治疗后治疗组CRP、PCT水平较对照组降低,差异具有统计学意义(P<0.05)。3血气分析:两组治疗后PH、Sa O2、Pa O2水平均较治疗前上升,Pa CO2水平均较治疗前下降,差异均具有统计学意义(P<0.05);治疗后治疗组较对照组p H、Sa O2、Pa O2水平升高,Pa CO2水平下降,差异均具有统计学意义(P<0.05)。结论:肺心标2号联合西医常规治疗可以更好地改善慢性肺源性心脏病急性加重期热痰证患者的临床症状、体征,减轻炎症反应,改善动脉血液气体分压。 展开更多
关键词 肺心标2 慢性肺源性心脏病 热痰证
下载PDF
Chaihushugan decoction exerts antiepileptic effects by increasing hippocampal glutamate metabolism in pentylenetetrazole-kindled rats 被引量:9
2
作者 Yu Yunhong Xie Wei Wang Changjun 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2015年第6期659-665,共7页
OBJECTIVE: To investigate the antiepileptic effects of Chaihushugan decoction(CHSGD) in rats with pentylenetetrazole(PTZ)-induced seizures and to discuss the impact of CHSGD on glutamate metabolism, a hypothesized und... OBJECTIVE: To investigate the antiepileptic effects of Chaihushugan decoction(CHSGD) in rats with pentylenetetrazole(PTZ)-induced seizures and to discuss the impact of CHSGD on glutamate metabolism, a hypothesized underlying mechanism of seizure reduction.METHODS: Fifty Wistar rats were divided randomly into either control(n = 10) or experimental(n = 40)groups. Rats in the control group were administered physiological saline intraperitoneally. A subconvulsive dose of PTZ(35 mg/kg) was administered intraperitoneally to rats in the experimental group to induce seizures. The fully PTZ-kindled rats were then randomly divided into five subgroups(n = 8 each) based on the following treatment categories: physiological saline, VPA(200 mg/kg), CHSGD(2.5 g/kg), CHSGD(5 g/kg), or CHSGD(10 g/kg),administered orally once per day, respectively. On day 28 following initiation of drug treatment, seizures were monitored. The rats were then sacrificed, and hippocampal dissections were performed for subsequent studies.RESULTS: CHSGD significantly prolonged the latency of myoclonic, clonic, and tonic seizures, while decreasing overall seizure rates in the kindled rats.The measured concentrations of 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-d-glucose(2-NBDG) and glutamate were significantly lower in the hippocampi of kindled rats in groups treated with CHSGD compared with those treated with PTZ alone. In addition, CHSGD was found to up-regulate both the expression of glutamate transporter-1(GLT-1) protein and the activity of glutamine synthetase(GS) in the hippocampi of kindled rats.CONCLUSION: These results suggest that CHSGD has antiepileptic effects on PTZ-induced seizures.The results further suggest an increase in glutamate metabolism at the synaptic cleft is a putative underlying mechanism of seizure reduction. 展开更多
关键词 Epilepsy PENTYLENETETRAZOLE Chaihushugan decoction 2-(N-(7-nitrobenz-2-oxa-1 3-diazol-4-yl)amino)-2-deoxyglucose Glutamic acid Glutamate plasma membrane transport proteins Glutamate-ammonia ligase
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部